v3 Template
R

Relation Therapeutics

Biotechnology ~500 employees
Founded
--
Employees (Est.)
~500
25 leaders known
Total Funding
$61.0M
Funding Rounds
2
Last Funding
2025-12-09

About Relation Therapeutics

Relation Therapeutics is an end-to-end biotech company focused on developing transformational medicines using technology. Their mission is to understand human biology in unprecedented ways to discover therapies for devastating diseases, leveraging single-cell multi-omics, functional assays, and machine learning to drive disease understanding from cause to cure.

Products & Services

Transformational Medicines:Medicines developed through high-resolution biology, machine learning, and clinical insights, targeting druggable targets for various diseases.
Osteoporosis Treatment:Announced as the first indication for their therapeutic development in March 2023.
Therapeutics for Fibrotic Diseases and Osteoarthritis:In collaboration with GSK, focusing on advancing treatments for these conditions.

Specialties

Single-cell multi-omics Genomics Machine Learning Drug Discovery High-resolution Biology Digital Biology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Unknown
T: -
FT: Unknown
A: 26000000
MR: -
FA: $26 million
FAN: 26000000
D: 2025-12-09
FD: 2025-12-09
3 investors
2 RT: Seed
T: -
FT: Seed
A: 35000000
MR: -
FA: $35 million
FAN: 35000000
D: 2024-03-14
FD: 2024-03-14
7 investors
Unknown Latest
2025-12-09
$26.0M
3 investors (Pro only)
Seed 2024-03-14
$35.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

David Roblin

Chief Executive Officer

LinkedIn (Pro only)
L

Lindsay Edwards

Chief Technology Officer

LinkedIn (Pro only)
R

Rosie Rodriguez

SVP Growth & Operations

LinkedIn (Pro only)
B

Benjamin Swerner

Chief Operating Officer

J

Jake Taylor-King

Chief Innovation Officer

C

Charles Roberts

Chair

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Relation Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~500 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro